Effects of repeated administrations of tafluprost, latanoprost, and travoprost on optic nerve head blood flow in conscious normal rabbits

Journal of Ocular Pharmacology and Therapeutics

Volumn 26, Issue 2, 2010, Pages 181-186

  Akaishi, Takahiro ^a   Kurashima, Hiroaki ^a   Odani Kawabata, Noriko ^a   Ishida, Naruhiro ^a   Nakamura, Masatsugu ^a  

^a SANTEN PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LATANOPROST; TAFLUPROST; TRAVOPROST;

ANIMAL EXPERIMENT; ARTICLE; BLOOD FLOW; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFECT; HEART RATE; MALE; NONHUMAN; OPTIC NERVE; REPEATED DRUG DOSE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD FLOW VELOCITY; CLOPROSTENOL; HEART RATE; LASER-DOPPLER FLOWMETRY; MALE; OPTIC DISK; PROSTAGLANDINS F; PROSTAGLANDINS F, SYNTHETIC; RABBITS; REGIONAL BLOOD FLOW; RETREATMENT;

EID: 77951677581     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2009.0100     Document Type: Article

References (31)

1. The AGIS Investigators. The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual fi eld deterioration. Am. J. Ophthalmol. 130: 429-440, 2000
2. Collaborative NTG Study Group. The effectiveness of IOP reduction in the treatment of NTG. Am. J. Ophthalmol. 126: 498-505, 1998.
3. Anderson, D. R., Drance, S. M., Schulzer, M.; Collaborative Normal-Tension Glaucoma Study Group. Factors that predict the benefi t of lowering intraocular pressure in normal tension glaucoma. Am. J. Ophthalmol. 136: 820-829, 2003. (Pubitemid 37330024)
4. Fechtner, R. D., and Weinreb, R. N. Mechanisms of optic nerve damage in primary open angle glaucoma. Surv. Ophthalmol. 39: 23-42, 1994.
5. Flammer, J., Orgül, S., Costa, V. P., et al. The impact of ocular blood fl ow in glaucoma. Prog. Retin. Eye Res. 21: 359-393, 2002.
6. Cioffi, G. A., and Sullivan, P. The effect of chronic ischemia on the primate optic nerve. Eur. J. Ophthalmol. 9: S34-S36, 1999. (Pubitemid 29179933)
7. Orgül, S., Cioffi, G. A., Bacon, D. R., et al. An endothelin-1-induced model of chronic optic nerve ischemia in rhesus monkeys. J. Glaucoma 5: 135-138, 1996. (Pubitemid 26139165)
8. Ciancaglini, M., Carpineto, P., Costagliola, C., et al. Perfusion of the optic nerve head and visual fi eld damage in glaucomatous patients. Graefes. Arch. Clin. Exp. Ophthalmol. 239: 549-555, 2001. (Pubitemid 32816173)
9. Yaoeda, K., Shirakashi, M., Fukushima, A., et al. Relationship between optic nerve head microcirculation and visual fi eld loss in glaucoma. Acta. Ophthalmol. Scand. 81: 253-259, 2003. (Pubitemid 36806263)
10. Ishida, N., Odani-Kawabata, N., Shimazaki, A., et al. Prostanoids in the therapy of glaucoma. Cardiovasc. Drug Rev. 24: 1-10, 2006. (Pubitemid 46696782)
11. Ishii, K., Tomidokoro, A., Nagahara, M., et al. Effects of topical latanoprost on optic nerve head circulation in rabbits, monkeys, and humans. Invest. Ophthalmol. Vis. Sci. 42: 2957-2963, 2001. (Pubitemid 33035296)
12. Vetrugno, M., Cantatore, F., Gigante, G., et al. Latanoprost 0.005% in POAG: effects on IOP and ocular blood fl ow. Acta. Ophthalmol. Scand. Suppl. 227: 40-41, 1998. (Pubitemid 29046198)
13. Georgopoulos, G. T., Diestelhorst, M., Fisher, R., et al. The shortterm effect of latanoprost on intraocular pressure and pulsatile ocular blood fl ow. Acta. Ophthalmol. Scand. 80: 54-58, 2002. (Pubitemid 34506344)
14. Liu, C. J., Ko, Y. C., Cheng, C. Y., et al. Effect of latanoprost 0. 005% and brimonidine tartrate 0.2% on pulsatile ocular blood fl ow in normal tension glaucoma. Br. J. Ophthalmol. 86: 1236-1239, 2002.
15. McKibbin, M., and Menage, M J. The Effect of Once-daily Latanoprost on Intraocular Pressure and Pulsatile Ocular Blood Fl Ow in Normal Tension Glaucoma. Eye. 13: 31-34, 1999.
16. Ohashi, M., Mayama, C., Ishii, K., et al. Effects of topical travoprost and unoprostone on optic nerve head circulation in normal rabbits. Curr. Eye. Res. 32: 743-749, 2007 (Pubitemid 47450625)
17. Nakaj ima, T., Matsugi, T., Goto, W., et al. New fl uoroprostaglandin F(2alpha) derivatives with prostanoid FP-receptor agonistic activity as potent ocular-hypotensive agents. Biol. Pharm. Bull. 26: 1691-1695, 2003. (Pubitemid 39663527)
18. Takagi, Y., Nakaj ima, T., Shimazaki, A., et al. Pharmacological characteristics of AFP-168 (tafl uprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug. Exp. Eye. Res. 78: 767-776, 2004. (Pubitemid 38252953)
19. Izumi, N., Nagaoka, T., Sato E., et al. Short-term effects of topical tafl uprost on retinal blood fl ow in cats. J. Ocul. Pharmacol. Ther. 24: 521-526, 2008.
20. Takahashi, A., Sato, E., Nagaoka, A., et al. Effect of topical tafl uprost on retinal and ocular nerve head circulation in normal human eyes. Association for Research in Vision & Ophthalmology. Invest. Ophthalmol. Vis. Sci. 48: E-Abstract 2280, 2007.
21. Tamaki, Y., Araie, M., Kawamoto, E., et al. Non-contact, twodimensional measurement of tissue circulation in the choroid and optic nerve head using laser speckle phenomenon. Exp. Eye. Res. 60: 373-384, 1995.
22. Briers, J. D., and Fercher, A. F. Retinal blood-fl ow visualization by means of laser speckle photography. Invest. Ophthalmol. Vis. Sci. 22: 255-259, 1982.
23. Roth, S The Effects of Halothane on Retinal and Choroidal Blood Fl Ow in Cats. Anesthesiology. 76: 455-460, 1992.
24. Roth, S., Pietrzyk, Z., and Crittenden, A. P. The effects of enfl urane on ocular blood fl ow. J. Ocul. Pharmacol. 9: 251-256, 1993. (Pubitemid 23309093)
25. Kuwayama, Y., and Yonemushi, S. PhaseIII confi rmatory study of 0.0015% DE-085 (Tafl uprost) ophthalmic solution in patients with open-angle glaucoma or ocular hypertension. Atarashii Ganka (J. Eye) 25: 1595-1602, 2008.
26. Eisenberg, D. L., Toris, C. B., and Camras, C. B. Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs. Surv. Ophthalmol. 47 (Suppl. 1): S105-S115, 2002.
27. Dong, Y., Watabe, H., Su, G., et al. Relaxing effect and mechanism of tafl uprost on isolated rabbit ciliary arteries. Exp. Eye Res. 87: 251-256, 2008.
28. Ishikawa, H., Yoshitomi, T., Mashimo, K., et al. Pharmacological effects of latanoprost, prostaglandin E2, and F2alpha on isolated rabbit ciliary artery. Graefes. Arch. Clin. Exp. Ophthalmol. 240: 120-125, 2002. (Pubitemid 36075586)
29. Kida, T., Sugiyama, T., Harino, S., et al. The effect of nipradilol, an alpha-beta blocker, on retinal blood fl ow in healthy volunteers. Curr. Eye Res. 23: 128-132, 2001. (Pubitemid 34499635)
30. Taniguchi, T., Kawakami, H., Tsuj i, A., et al. Effects of prostaglandin-related drug on the intraocular pressure and blood-aqueous barrier in rabbits. Atarashii Ganka (J. Eye) 14: 1831-1833, 1997.
31. Hellberg, M. R., Sallee, V. L., McLaughlin, M. A., et al. Preclinical effi cacy of travoprost, a potent and selective FP prostaglandin receptor agonist. J. Ocul. Pharmacol. Ther. 17: 421-432, 2001.